1. EPR3 National Asthma Education and Prevention Program.
Expert Panel Report #3: Guidelines for the Diagnosis and Management of Asthma.
NIH Publication No. 07-4051. Bethesda, MD: US Department of Health and Human Services;
National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma
Education and Prevention Program; August 2007.
2. Kemp JP, Skoner DP, Szefler SJ, Walton-Bowen K, Cruz-Rivera M, Smith JA.
Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and
young children. Ann Allergy Asthma Immunol. 1999;83(3):231-239.
3. Data on file, DA-RES-04.
4. Shapiro G, Mendelson L, Kraemer MJ, Cruz-Rivera M, Walton-Bowen K, Smith JA.
Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children
with inhaled steroid-dependent, persistent asthma. J Allergy Clin Immunol. 1998;102(5):789-796.
5. Baker JW, Mellon M, Wald J, Welch M, Cruz-Rivera M, Walton-Bowen K. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics. 1999;103(2):414-421.
6. Data on file, DA-RES-09.
7. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med. 2001;344(5):350-362.
8. Barnes PJ, Adcock IM. How do corticosteroids work in asthma? Ann Intern Med. 2003;139(5 pt 1):359-370.
9. Hood PP, Cotter TP, Costello JF, Sampson AP. Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients. Thorax. 1999;54(12):1075-1082.
10. Scott MB, Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol. 1999;104(4 pt 2):200-209.
11. Macias CG, Caviness AC, Sockrider M, et al. The effect of acute and chronic asthma severity on pediatric emergency department utilization. Pediatrics. 2006;117(4 pt 2):S86-S95.
12. Castro-RodrÃguez JA, Holberg CJ, Wright AL, Martinez FD.
A clinical index to define risk of asthma in young children with recurrent wheezing.
Am J Respir Crit Care Med. 2000;162(4 pt 1):1403-1406.
13. Guilbert TW, Morgan WJ, Zeiger RS, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114(6):1282-1287.
14. Warschburger P, von Schwerin AD, Buchholz HT, Petermann F. An educational program for parents of asthmatic preschool children: short- and medium-term effects. Patient Educ Couns. 2003;51(1):83-91.
15. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, healthcare utilization, and mortality. Pediatrics. 2002;110(2 pt 1):315-322.
16. Orrell-Valente JK, Jarlsberg LG, Rait MA, Thyne SM, Rubash T, Cabana MD. Parents' specific concerns about daily asthma medications for children. J Asthma. 2007;44(5):385-390.
17. Brock TP, Williams DM. Clinical considerations in the use of inhalation delivery devices. J Pharm Pract. 2001;14(4):277-295.
18. Liu AN, Covar RA, Spahn JD, Leung DYM. Childhood asthma. In: Kliegman RM, Behrman RE, Jenson HB, Stanton FF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: Saunders-Elsevier; 2007.
19. Zhong W, Levin L, Reponen T, et al. Analysis of short-term influences of ambient aeroallergens on pediatric asthma hospital visits. Sci Total Environ. 2006;370(2-3):330-336.
20. Sahakian NM, Park JH, Cox-Ganser JM. Dampness and mold in the indoor environment: implications for asthma. Immunol Allergy Clin North Am. 2008;28(3):485-505.
21. Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am. 2008;28(3):539-561, viii.
22. Sears MR, Johnston NW. Understanding the September asthma epidemic. J Allergy Clin Immunol. 2007;120(3):526-529.
23. PULMICORT RESPULES [package insert]. Wilmington, DE: AstraZeneca LP; 2007.